Speaker illustration

Doctor Ana Filipa Fonseca

Novartis Sweden AB, Stockholm (Sweden)

Concordance between patient and physician reported symptoms in patients with heart failure and a LVEF equal to or less than 60%: a multinational survey in the EU

Event: ESC Congress 2020

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic Heart Failure ePosters

Thumbnail

A real-world assessment of the distribution of lipid levels across increasing lipoprotein(a) levels in patients with established cardiovascular disease in the United States

Event: ESC Congress 2020

Topic: Lipids

Session: Risk Factors and Prevention ePosters

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb